Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
0.9826
-0.0011 (-0.11%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Unity Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1716323984277
Upgrade
Market Cap Growth
-36.27%-49.21%-16.69%-53.86%-69.60%-16.30%
Upgrade
Enterprise Value
221214-1457209
Upgrade
Last Close Price
0.980.981.932.7414.6052.40
Upgrade
PS Ratio
---164.7817.62-
Upgrade
PB Ratio
-82.032.531.140.691.423.35
Upgrade
P/TBV Ratio
-2.531.140.691.423.35
Upgrade
EV/Sales Ratio
----11.82-
Upgrade
Debt / Equity Ratio
-110.283.630.950.900.960.77
Upgrade
Asset Turnover
---0.000.03-
Upgrade
Quick Ratio
1.872.525.714.845.306.76
Upgrade
Current Ratio
1.952.625.954.925.456.97
Upgrade
Return on Equity (ROE)
-231.27%-148.97%-94.36%-76.90%-85.26%-92.19%
Upgrade
Return on Assets (ROA)
-38.89%-34.43%-25.30%-27.94%-25.20%-37.12%
Upgrade
Return on Capital (ROIC)
-47.83%-41.66%-29.69%-31.20%-26.95%-42.75%
Upgrade
Earnings Yield
-163.54%-157.97%-123.04%-114.36%-72.05%-33.85%
Upgrade
FCF Yield
-131.06%-126.82%-114.52%-135.03%-53.70%-28.48%
Upgrade
Buyback Yield / Dilution
-9.46%-13.90%-55.60%-70.10%-9.73%-16.60%
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q